Ocular Therapeutix, Inc. (OCUL)
NASDAQ: OCUL · Real-Time Price · USD
8.65
-0.14 (-1.54%)
Nov 21, 2024, 12:33 PM EST - Market open
Ocular Therapeutix Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 61.44 | 58.44 | 51.49 | 43.52 | 17.4 | 4.23 | Upgrade
|
| Revenue Growth (YoY) | 6.45% | 13.49% | 18.32% | 150.08% | 311.71% | 112.41% | Upgrade
|
| Cost of Revenue | 108.62 | 66.34 | 58 | 54.49 | 30.78 | 43.42 | Upgrade
|
| Gross Profit | -47.18 | -7.89 | -6.51 | -10.97 | -13.37 | -39.19 | Upgrade
|
| Selling, General & Admin | 94.07 | 74.49 | 72.15 | 67.07 | 49.47 | 46.61 | Upgrade
|
| Operating Expenses | 94.07 | 74.49 | 72.15 | 67.07 | 49.47 | 46.61 | Upgrade
|
| Operating Income | -141.26 | -82.38 | -78.65 | -78.04 | -62.85 | -85.8 | Upgrade
|
| Interest Expense | -14.62 | -11.34 | -7.02 | -6.67 | -6.77 | -6.1 | Upgrade
|
| Interest & Investment Income | 17.07 | 3.98 | 0.8 | 0.03 | 0.17 | 1.23 | Upgrade
|
| Other Non Operating Income (Expenses) | -7.58 | -5.19 | 13.84 | 78.12 | -86.19 | 4.3 | Upgrade
|
| EBT Excluding Unusual Items | -146.39 | -94.93 | -71.04 | -6.55 | -155.64 | -86.37 | Upgrade
|
| Other Unusual Items | -27.95 | 14.19 | - | - | - | - | Upgrade
|
| Pretax Income | -174.34 | -80.74 | -71.04 | -6.55 | -155.64 | -86.37 | Upgrade
|
| Net Income | -174.34 | -80.74 | -71.04 | -6.55 | -155.64 | -86.37 | Upgrade
|
| Net Income to Common | -174.34 | -80.74 | -71.04 | -6.55 | -155.64 | -86.37 | Upgrade
|
| Shares Outstanding (Basic) | 137 | 80 | 77 | 76 | 61 | 45 | Upgrade
|
| Shares Outstanding (Diluted) | 137 | 86 | 83 | 82 | 61 | 45 | Upgrade
|
| Shares Change (YoY) | 76.20% | 3.57% | 0.59% | 35.24% | 34.19% | 18.78% | Upgrade
|
| EPS (Basic) | -1.27 | -1.01 | -0.92 | -0.09 | -2.56 | -1.91 | Upgrade
|
| EPS (Diluted) | -1.27 | -1.02 | -0.97 | -0.98 | -2.56 | -1.91 | Upgrade
|
| Free Cash Flow | -119.25 | -76.32 | -63.32 | -66.74 | -54.4 | -79.82 | Upgrade
|
| Free Cash Flow Per Share | -0.87 | -0.89 | -0.77 | -0.81 | -0.90 | -1.76 | Upgrade
|
| Gross Margin | -76.79% | -13.51% | -12.64% | -25.20% | -76.85% | - | Upgrade
|
| Operating Margin | -229.90% | -140.96% | -152.74% | -179.30% | -361.13% | -2029.86% | Upgrade
|
| Profit Margin | -283.74% | -138.14% | -137.95% | -15.06% | -894.31% | -2043.34% | Upgrade
|
| Free Cash Flow Margin | -194.08% | -130.59% | -122.96% | -153.36% | -312.56% | -1888.24% | Upgrade
|
| EBITDA | -137.46 | -79.4 | -76.55 | -75.62 | -60.07 | -83.27 | Upgrade
|
| EBITDA Margin | -223.73% | -135.86% | -148.65% | -173.74% | - | - | Upgrade
|
| D&A For EBITDA | 3.79 | 2.98 | 2.11 | 2.42 | 2.77 | 2.53 | Upgrade
|
| EBIT | -141.26 | -82.38 | -78.65 | -78.04 | -62.85 | -85.8 | Upgrade
|
| EBIT Margin | -229.90% | -140.96% | -152.74% | -179.30% | - | - | Upgrade
|
| Revenue as Reported | 61.44 | 58.44 | 51.49 | 43.52 | 17.4 | 4.23 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.